Latest news and press releases about Avanos Medical, Inc. (AVNS): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management.
Price
| Price | $24.99 |
| Market Cap | $1.2B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| Price / Book | 1.48 |
| EV / EBITDA | -57.57 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -8.91% |
| Return on Invested Capital | -6.03% |
| Return on Assets | -6.61% |
| Gross Margin | 48.55% |
| Operating Margin | -7.92% |
| Net Margin | -9.69% |
Related companies: AORT · AXGN · CVSA · ITGR · LIVN · VREX
Explore sector: Healthcare · Medical - Devices
More sections of AVNS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks